Biomarkers and advances in AML-MRC: from bench to bedside

Abstract Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) represents a high-risk subtype of AML, characterized by poor prognosis and limited therapeutic options. Recent updates in the WHO and ICC classifications have redefined AML-MRC, emphasizing molecular and cytogenetic criter...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Fanlin Meng, Zahraa Al-Khafaji, Khursheed Muzammil, Ehsan Sarbazjoda, Mohammad Navid Khaksari, Alireza Bayani, Hamed Soleimani Samarkhazan
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Springer 2026-02-01
Цуврал:	Annals of Hematology
Нөхцлүүд:	AML-MRC Biomarkers Precision medicine Next-generation sequencing Targeted therapy
Онлайн хандалт:	https://doi.org/10.1007/s00277-026-06805-8
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!